Search

Your search keyword '"Timothy D Henry"' showing total 871 results

Search Constraints

Start Over You searched for: Author "Timothy D Henry" Remove constraint Author: "Timothy D Henry"
871 results on '"Timothy D Henry"'

Search Results

1. Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial

2. Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials.

Catalog

Books, media, physical & digital resources

3. Enhanced External Counterpulsation Improves Dyspnea, Fatigue, and Functional Capacity in Patients with Long COVID

4. SCAI Expert Consensus Statement on the Management of Patients With STEMI Referred for Primary PCI

7. Evaluation of coronary microvascular dysfunction using magnetocardiography: A new application to an old technology

8. Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients

9. Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction

10. INOCA/ANOCA: Mechanisms and novel treatments

11. STEMI care 2021: Addressing the knowledge gaps

13. First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients

14. Interaction of COVID-19 With Common Cardiovascular Disorders

16. Impact of COVID-19 on Acute Myocardial Infarction Care

18. Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure

20. Mechanical Circulatory Support in Patients With COVID-19 Presenting With Myocardial Infarction

22. Eligibility of out-of-hospital cardiac arrest patients for extracorporeal cardiopulmonary resuscitation in the United States: A geographic information system model

23. Revascularization and long‐term outcomes in high‐acuity spontaneous coronary artery dissection

24. Contemporary Management of Refractory Angina

25. Management Principles for the Cardiac Catheterization Laboratory During the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Pandemic

28. Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols

29. Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19

30. Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging

32. Characteristics and Long-term Mortality in Patients with ST-Segment Elevation Myocardial Infarction with Non-Obstructive Coronary Arteries (STE-MINOCA): A High Risk Cohort

33. Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations

34. On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES

35. 761 PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY

36. Personalized vascular healthcare: insights from a large international survey

37. Frequency and outcomes of STEMI patients presenting between 12 and 24 h after symptom onset: Late-presenting STEMI

38. Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out-Of-Pocket Expenses? Insights From ARTEMIS

40. Comparison of Outcomes of Patients with vs without Previous Coronary Artery Bypass Graft Surgery Presenting with ST-Segment Elevation Acute Myocardial Infarction

42. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design

43. Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarction

44. Mechanical Circulatory Support in COVID-19

45. Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock

46. Cardiology Research Internship for Undergraduate Students Provides Unique Opportunity for Next Generation of Health Care Professionals

47. Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials

48. A Phase <scp>II</scp> study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the <scp>CCTRN CONCERT‐HF</scp> trial

49. Initial Findings From the North American COVID-19 Myocardial Infarction Registry